![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Assistance Publique - Hôpitaux de Paris |
Information provided by: | Assistance Publique - Hôpitaux de Paris |
ClinicalTrials.gov Identifier: | NCT00162591 |
The aim of this protocol is to study the prophylactic effect of remifentanil on bispectral index variation during a nociceptive stimuli.
Condition | Intervention |
Pain |
Drug: remifentanyl |
ChemIDplus related topics: | Remifentanil Remifentanil hydrochloride |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl |
Estimated Enrollment: | 40 |
Study Start Date: | October 2004 |
Pain is difficult to estimate in ICU because most of the patients are sedated. Bispectral index could be helpful in detecting this pain in ICU patients. Remifentanil is a morphinomimetic product with short half life that could be interesting for short nociceptive stimuli, as bronchoalveolar lavage.
The purpose of this study is to evaluate the impact of remifentanil infusion on bispectral index (BIS) variations during bronchoalveolar lavage.
It is a prospective, double blind study, versus placebo on 40 sedated and critically ill patients.
The hypothesis is that BIS can study analgesia in sedated patient.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: QUINTARD h Hervé, MD | +33140258816 | quintard@libertysurf.fr |
France | |||||
Surgical ICU Bichat Claude Bernard | Recruiting | ||||
Paris, France, 75018 | |||||
Contact: QUINTARD H Hervé, MD +33140258116 quintard@libertysurf.fr | |||||
Principal Investigator: QUINTARD H Hervé, MD |
Assistance Publique - Hôpitaux de Paris |
Principal Investigator: | QUINTARD H Hervé, MD | Surgical ICU Bichat Claude Bernard (Paris, France) |
Study ID Numbers: | P040201 AT/AT/04-116 |
First Received: | September 10, 2005 |
Last Updated: | November 21, 2005 |
ClinicalTrials.gov Identifier: | NCT00162591 |
Health Authority: | France: Ethics Commitee of Paris Bichat Claude Bernard |
|
|
|
|
|
![]() |